4ARRAS33A C, FRUCHTER, CLARK M, et al. Uterine incidence and trends in management and survival[J]. Gynecol Oncol, 1997, 65: 158-163.
5MAJOR F J, BLESSING J A, SILVERBERG S G, et al. Prognostic factors in early stage uterine sawoma a Gynecological Oncology Group study[J]. Cancer, 1993, 71(Suppl): 1702- 1709.
7Lu C H,Chen 1 H, Chen Y J, ei al. Primary treatment and prog-nostic factors of carcinosarcoma of the ovary, fallopian tube,andperitoneum: a Taiwan Residents gynecologic oncology group study[ J] . IntJ Gynecol Cancer, 2014,24(3) :506 - 12.
8Zorzou M P, Markaki S,Rodolakis A,et al. Clinicopathologicalfeatures of ovarian carcinosarcomas : a single institution experience[J]. Gynecol Oncol, 2005 ,96( 1 ) : 136 -42.
9Harris M A, Delap L M,Sengupta P et al. Carcinosarcoma ofthe ovary [J] . Br J Cancer, 2003 ,88(5 ) :654 -7.
10Brown E, Stewart M, Rye T, et al. Carcinosarcoma of the ovary :19years of prospective data from a single center [ J ]. Cancer,2004,100(10):2148-53.
